A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial)

@inproceedings{Anker2015APC,
  title={A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial)},
  author={Stefan D. Anker and Andrew J. S. Coats and Gabriel Cristian and Dinu Dragomir and Enrico Pusineri and Massimo Piredda and Luca Bettari and Robert A Dowling and Maurizio Volterrani and B Kirwan and Gerasimos Filippatos and J R Perez Mas and Nicolas Danchin and Scott Solomon and Randall J. Lee and Frank Ahmann and Andy Hinson and Hani N. Sabbah and Douglas L. Mann},
  booktitle={European heart journal},
  year={2015}
}
AIMS AUGMENT-HF was an international, multi-centre, prospective, randomized, controlled trial to evaluate the benefits and safety of a novel method of left ventricular (LV) modification with alginate-hydrogel. METHODS Alginate-hydrogel is an inert permanent implant that is directly injected into LV heart muscle and serves as a prosthetic scaffold to modify the shape and size of the dilated LV. Patients with advanced chronic heart failure (HF) were randomized (1 : 1) to alginate-hydrogel (n… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 6 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 26 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 26 references

Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency

  • P Ponikowski, DJ van Veldhuisen, +13 authors Investigators. CONFIRM-HF
  • Eur Heart J 2015;36:657–668
  • 2015
1 Excerpt

Similar Papers

Loading similar papers…